Corticosterone response to the plus-maze: High correlation with risk assessment in rats and mice

Physiology and Behavior

Volumn 68, Issue 1-2, 1999, Pages 47-53

  Rodgers, R J ^a   Haller, J ^b   Holmes, A ^a   Halasz, J ^b   Walton, T J ^c   Brain, P F ^c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Elevated plus maze; Mice; Plasma corticosterone; Rats; Risk assessment; Stretched attend postures

Indexed keywords

CORTICOSTERONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CORTICOSTERONE BLOOD LEVEL; EXPLORATORY BEHAVIOR; LATENT PERIOD; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; SKIN CONDUCTANCE;

EID: 0033430166     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(99)00140-7     Document Type: Article

References (61)

1. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav. 54:1996;21-30.
2. Rodgers R.J. Animal models of anxiety. Where next? Behav Pharmacol. 8:1997;477-496.
3. Rodgers R.J., Cole J.C. The elevated plus-maze. Pharmacology, methodology and ethology Cooper S.J., Hendrie C.A. Ethology and Psychopharmacology. 1994;9-44 John Wiley & Sons Ltd, Chichester.
4. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 14:1985;149-167.
5. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berlin). 92:1987;180-185.
6. File S.E. Behavioural detection of anxiolytic action. Elliott J.M., Heal D.J., Marsden C.A. Experimental Approaches to Anxiety and Depression. 1992;25-44 John Wiley & Sons Ltd; London.
7. Trullas R., Skolnick P. Difference in fear motivated behaviors among inbred mouse strains. Psychopharmacology (Berlin). 111:1993;323-331.
8. Cruz A.P.M., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav. 49:1994;171-176.
9. Espejo E.F. Structure of mouse behavior in the elevated plus-maze test of anxiety. Behav Brain Res. 86:1997;105-112.
10. Fernandes C., File S.E. The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol Biochem Behav. 54:1996;31-40.
11. Holmes A., Rodgers R.J. Responses of Swiss-Webster mice to repeated plus-maze experience. Further evidence for a qualitative shift in emotional state? Pharmacol Biochem Behav. 60:1998;473-488.
12. McCreary A.C., McBlane J.W., Spooner A., Handley S.L. 5-HT systems and anxiety. Multiple mechanisms in the elevated X-maze Pol J Pharmacol. 48:1996;1-12.
13. Rodgers R.J., Johnson N.J.T. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav. 52:1995;297-303.
14. Cole J.C., Rodgers R.J. Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test. Comparison with haloperidol Psychopharmacology (Berlin). 114:1994;288-296.
15. Griebel G., Rodgers R.J., Perrault G., Sanger D.J. Risk assessment behaviour. evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test Pharmacol Biochem Behav. 57:1997;817-827.
16. Setem J., Pinheiro A.P., Motta V.A., Morato S., Cruz A.P.M. Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze. Pharmacol Biochem Behav. 62:1999;515-521.
17. Suer C., Dolu N., Ozesmi C., Sahin O., Ulgen A. The relation between skin conductance level and plus-maze behaviour in male mice. Physiol Behav. 64:1998;573-576.
18. Haller J., Halasz J., Makara G.B., Kruk M.R. Acute effects of glucocorticoids. Behavioral and pharmacological perspectives Neurosci Biobehav Rev. 23:1998;337-344.
19. Koolhaas J.M., de Boer S.F., de Rutter A.J.H., Meerlo P., Sgoifo A. Social stress in rats and mice. Acta Physiol Scand. 161:1997;69-72.
20. Calvo N., Martijena I.D., Molina V.A., Volosin M. Metyrapone pretreatment prevents the behavioral and neurochemical sequelae induced by stress. Brain Res. 800:1998;227-235.
21. Copland A.M., Balfour D.J.K. Spontaneous activity and brain 5-hydroxyindole levels measured in rats tested in two designs of elevated X-maze. Life Sci. 41:1987;57-64.
22. File S.E., Johnston A.L., Baldwin H.A. Anxiolytic and anxiogenic drugs. Changes in behaviour and endocrine responses Stress Med. 4:1988;221-230.
23. File S.E., Zangrossi H., Sanders F.L., Mabbutt P.S. Raised corticosterone after exposure to the elevated plus-maze. Psychopharmacology (Berlin). 113:1994;543-546.
24. Holmes A., Diffley E.P., Walton T.J., Brain P.F., Rodgers R.J. Lack of habituation of corticosterone response in mice repeatedly exposed to the plus-maze. J Psychopharmac. 12S:1998;32.
25. Elenkov I.L., Kovacs K., Kiss J., Bertok L., Vizi E.S. Lipopolysaccharide is able to bypass corticotropin-releasing factor in affecting plasma ACTH and corticosterone levels. Evidence from rats with lesions of the paraventricular nucleus J Endocrinol. 133:1992;231-236.
26. Gomez-Sanchez C., Milewich L., Holland O.B. Radioiodinated derivatives for steroid immunoassay. Application to the radioimmunoassay of cortisol. J Lab Clin Med. 80:1977;902-909.
27. Weiss SM. Pharmacological and behavioural examination of the defensive reactions of laboratory mice to the calls of the Tawny Owl (Strix aluco). PhD Thesis, University of Leeds, 1995.
28. Blanchard R.J., Blanchard D.C. Antipredator defensive behaviors in a visible burrow system. J Comp Psychol. 103:1989;70-82.
29. Blanchard R.J., Parmigiani S., Bjornson C., Masuda C., Weiss S.M., Blanchard D.C. Antipredator behavior of Swiss-Webster mice in a visible burrow system. Aggress Behav. 21:1995;123-136.
30. Blanchard R.J., Nikulina J.N., Sakai R.R., McKittrick C., McEwen B.S., Blanchard D.C. Behavioral and endocrine change following chronic predatory stress. Physiol Behav. 63:1998;561-569.
31. de Quervain D.J.-F., Roozendaal B., McGaugh J.L. Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature. 394:1998;787-790.
32. Turner S.W., Wen C., Li M., Fraser T.B., Whitworth J.A. Adrenocorticotropin dose-response relationships in the rat. haemodynamic, metabolic and hormonal effects J Hypertens. 16:1998;593-600.
33. Azpiroz A., Fano E., Garmendia L., Arregi A., Cacho R., Beitia G., Brain P.F. Effects of chronic mild stress (CMS) and imipramine administration, on spleen mononuclear cell proliferative response, serum corticosterone level and brain norepinephrine content in male mice. Psychoneuroendocrinology. 24:1999;345-361.
34. Chapman J.C., Christian J.J., Pawlikowski M.A., Michael S.D. Analysis of steroid hormone levels in female mice at high population density. Physiol Behav. 64:1998;529-533.
35. Coleman M.A., Garland T., Marler C.A., Newton S.S., Swallow J.G., Carter P.A. Glucocorticoid response to forced exercise in laboratory house mice (Mus domesticus). Physiol Behav. 63:1998;157-164.
36. Grant E.C., Mackintosh J.H. A comparsion of the social postures of some common laboratory rodents. Behaviour. 21:1963;246-259.
37. Kaesermann H.-P. Streteched attend posture, a non-social form of ambivalence, is sensitive to a conflict-reducing drug action. Psychopharmacology (Berlin). 89:1986;31-37.
38. van der Poel A.M. A note on "stretched attention," a behavioural element indicative of an approach-avoidance conflict in rats. Anim Behav. 27:1979;446-450.
39. Pinel J.P.J., Mana M.J. Adaptive interactions of rats with dangerous inanimate objects. Support for a cognitive theory of defensive behavior Blanchard R.J., Brain P.F., Blanchard D.C., Parmigiani S. Ethoexperimental Approaches to the Study of Behavior. 1993;137-150 Kluwer Aacdemic Publications, Dordrecht.
40. Blanchard R.J., Yudko E.B., Rodgers R.J., Blanchard D.C. Defense system psychopharmacology. An ethological approach to the pharmacology of fear and anxiety Behav Brain Res. 58:1993;155-165.
41. Grewal S.S., Shepherd J.K., Bill D.J., Fletcher A., Dourish C.T. Behavioural and pharmacological characterisation of the canopy stretched attend posture test as a model of anxiety in mice and rats. Psychopharmacology (Berlin). 133:1997;29-38.
42. Molewijk H.E., van der Poel A.M., Olivier B. The ambivalent behaviour "stretched approach posture" in the rat as a paradigm to characterize anxiiolytic drugs. Psychopharmacology (Berlin). 121:1995;81-90.
43. Rodgers R.J., Cole J.C., Cobain M.R., Daly P., Doran P.J., Eells J.R., Wallis P. Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze. Profile comparisons with 8-OH-DPAT, CGS12066B, TFMPP and mCPP Behav Pharmacol. 3:1992;621-634.
44. Shepherd J.K., Grewal S.S., Fletcher A., Bill D.J., Dourish C.T. Behavioural and pharmacological characterisation of the elevated zero-maze as an animal model of anxiety. Psychopharmacology (Berlin). 116:1994;56-64.
45. McNaugthon N. Cognitive dysfunction resulting from hippocampal hyperactivity - A possible cause of anxiety disorder? Pharmacol Biochem Behav. 56:1997;603-611.
46. Meijer O.C., de Kloet E.R. Corticosterone and serotonergic neurotransmission in the hippocampus. Functional implications of central corticosteroid receptor diversity Crit Rev Neurobiol. 12:1998;1-20.
47. Rodgers R.J., Johnson N.J.T., Carr J., Hodgson T.P. Resistance of experientially-induced changes in murine plus-maze behaviour to altered retest conditions. Behav Brain Res. 86:1997;71-77.
48. Rodgers R.J., Johnson N.J.T., Cole J.C., Dewar C.V., Kidd G.R., Kimpson P.H. Plus-maze retest profile. Importance of initial stages of trial 1 and response to post-trial cholinergic receptor blockade in mice Pharmacol Biochem Behav. 54:1996;41-50.
49. Shepherd JK. Preliminary analysis of an elevated "zero-maze" as a model of anxiety in laboratory rats. Paper delivered to the British Association for Psychopharmacology, Cambridge, July 1992.
50. De Boer S.F., Koopmans S.L., Slangen J.L., van der Gugten J. Plasma catecholamine, corticosterone and glucose responses to repeated stress in rats. Effects of interstressor interval Physiol Behav. 47:1990;1117-1124.
51. Smythe J.W., Murphy D., Timothy C., Costall B. Exogenous corticosterone administration increases anxiety in rats. Br J Pharmacol. 117:1996;182P.
52. Andreatini R., Leite J.R. The effect of corticosterone in rats submitted to the elevated plus-maze and pentylenetetrazol-induced convulsions. Prog Neuropsychopharmacol Biol Psychiatry. 18:1994;1333-1347.
53. McBlane J.W., Handley S.L. Effects of two stressors on behaviour in the elevated X-maze. Preliminary investigation of their interaction with 8-OH-DPAT Psychopharmacology (Berlin). 116:1994;173-182.
54. Mason J.W. "Overall" hormonal balance as a key to endocrine organisation. Psychosom Med. 30:1968;791-808.
55. File S.E. Interactions of anxiolytic and antidepressant drugs with hormones of the hypothalamic-pituitary-adrenal axis. File S.E. Psychopharmacology of Anxiolytics and Antidepressants. 1991;29-55 Pergamon Press; New York.
56. Roozendaal B., Bohus B., McGaugh J.L. Dose-dependent suppression of adrenocortical activity with metyrapone. Effects on emotion and memory Psychoneuroendcocrinology. 21:1996;681-693.
57. Korte S.M., de Boer S.F., de Kloet E.R., Bohus B. Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behaviour in the elevated plus-maze. Psychoneuroendocrinology. 20:1995;385-394.
58. Korte S.M., Korte-Bouws G.A.H., Koob G.F., de Kloet E.R., Bohus B. Mineralocorticoid and glucocorticoid receptor antagonists in animal models of anxiety. Pharmacol Biochem Behav. 54:1996;261.
59. Smythe J.W., Murphy D., Timothy C., Costall B. Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behaviour in rats. Pharmacol Biochem Behav. 56:1997;507-513.
60. Rochford J., Beaulieu S., Rousse I., Glowa J.R., Barden N. Behavioral reactivity to aversive stimuli in a transgenic mouse model of impaired glucocorticoid (type II) receptor function. Effects of diazepam and FG-7142 Psychopharmacology (Berlin). 132:1997;145-152.
61. Weinstock M., Poltyrev T., Schorer-Apelabum D., Men D., McCarty R. Effects of prenatal stress on plasma corticosterone and catecholamines in response to footshock in rats. Physiol Behav. 64:1998;439-444.